UBS analyst Jon Windham lowered the firm’s price target on Stem to $18 from $19 and keeps a Buy rating on the shares. The company revised Q4 revenue and profitability guidance downward and increased expected Q4 bookings, Windham tells investors in a research note. The analyst believes bookings remain the key near-term metric and expects the easing of supply chains combined with operating leverage to drive increasing profitability for Stem in 2023.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on STEM: